CFTR and cystic fibrosis: However, treatment with CFTR modulators reduced the expression of mesenchymal markers in CF patient-derived endothelial cells, suggesting potential therapeutic benefits of CFTR modifiers beyond correcting defective CFTR-mediated ion transport (Treps et al., 2021).